查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587262

感冒和流感补充品市场：按类型、形式和分销管道划分 - 2025-2030 年全球预测

Cold & Flu Supplements Market by Type (Herbal Extracts, Homeopathic, Natural Molecules), Form (Pills & Capsules, Powders, Syrups), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年感冒和流感补充品市场价值为167.8亿美元，预计到2024年将达到185.7亿美元，复合年增长率为10.90%，预计到2030年将达到346.5亿美元。

感冒和流感补充品市场包括旨在增强免疫功能并缓解与普通感冒和流感相关症状的营养产品。这些补充品通常包括维生素、矿物质、草药和胺基酸，通常用于支持整体免疫健康并减轻症状的严重。这些补充品被认为对于预防病毒感染和更快恢復很重要，尤其是在秋季和冬季等旺季。这些补充品被各种消费群体使用，包括儿童、成人和老年人，最终用户包括注重健康的人以及寻求传统药物之外的替代疗法的人。

主要市场统计
基准年[2023] 167.8亿美元
预测年份 [2024] 185.7亿美元
预测年份 [2030] 346.5亿美元
复合年增长率（%） 10.90%

由于健康意识的提高，特别是在最近强调免疫弹性的全球健康危机之后，这个市场正在蓬勃发展。预防保健和天然补充品的趋势以及线上销售管道的市场扩张正在推动显着成长。配方创新和个人化营养的不断增长趋势正在为产品开发开闢新途径，以适应更个人化的消费者体验。儘管有这些成长要素，市场仍面临重大挑战，包括监管障碍、产品功效临床检验的需求以及来自药品的竞争。消费者对某些补充品功效的怀疑使市场动态更加复杂。

潜在的商机在于研究和创新，特别是开发经过科学证明具有健康益处的补充品。公司可以利用数位平台实施创新行销策略和消费者教育倡议，从而提高产品可信度。此外，扩展到新兴市场使我们能够接触到更广泛的愿意投资预防性医疗解决方案的消费者。然而，公司必须保持透明的标籤并收集大量的科学证据，以减少监管挑战并克服消费者的怀疑。这个市场需要持续创新、消费者参与并专注于扎实的临床研究，以维持成长并建立消费者对寻求有效健康干预措施的信任。

市场动态：快速发展的感冒和流感补充品市场的关键市场洞察

感冒和流感补充品市场正在因供需的动态相互作用而转变。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 老龄化社会中季节性疾病的爆发和对免疫健康的担忧
    • 透过政府健康计画和措施提高消费者意识
    • 人们越来越偏好天然和补充品补充品
  • 市场限制因素
    • 药物替代品的普及
  • 市场机会
    • 不断推出新开发的增强免疫力的补充品
    • 拓展超级市场及网路销售管道
  • 市场挑战
    • 维持产品品质和遵守监管要求的挑战

波特的五力：驾驭感冒和流感补充品市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解感冒和流感补充品市场的外部影响

外部宏观环境因素对感冒和流感补充品市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助企业预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解感冒和流感补充品市场的竞争状况

对感冒和流感补充品市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵感冒和流感补充品市场供应商的绩效评估

FPNV定位矩阵是评估感冒和流感补充品市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，规划感冒和流感补充品市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对感冒和流感补充品市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 季节性疾病爆发和对老年人免疫健康的担忧
      • 透过政府健康计画和措施提高消费者意识
      • 对天然和草药补充品的新偏好
    • 抑制因素
      • 药物替代品的更广泛可用性
    • 机会
      • 不断推出新开发的免疫力增强补充品
      • 拓展超级市场及网上分销通路
    • 任务
      • 与维持产品品质和遵守监管要求相关的挑战
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章感冒和流感补充品市场：按类型

  • 草药萃取物
  • 同类疗法
  • 天然分子
  • 维生素和矿物质

第七章感冒和流感补充品市场：按形式

  • 锭剂和胶囊
  • 粉末
  • 糖浆

第八章感冒和流感补充品市场：按分销管道

  • 线上和电子商务平台
  • 药局/药局

第九章北美和南美感冒和流感补充品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太感冒及流感补充品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的感冒和流感补充品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Amway International Inc.
  • Bayer AG
  • Church & Dwight Co., Inc.
  • GlaxoSmithKline PLC
  • Haleon PLC
  • Himalaya Global Holdings Ltd.
  • Johnson & Johnson Services Inc.
  • Medique Products
  • Mondelez Global LLC
  • Nature's Sunshine Products, Inc.
  • Nature's Way, Inc.
  • Neurobiologix, Inc.
  • Nutraceutical Corporation
  • Perrigo Company PLC
  • Reckitt Benckiser Group PLC
  • Sambucol by PharmaCare Laboratories Pty Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • The Menarini Group
  • The Procter & Gamble Company
  • Thornton and Ross Limited by STADA Group
  • Wakunaga Pharmaceutical Co., Ltd.
Product Code: MRR-521BAA36EA80

The Cold & Flu Supplements Market was valued at USD 16.78 billion in 2023, expected to reach USD 18.57 billion in 2024, and is projected to grow at a CAGR of 10.90%, to USD 34.65 billion by 2030.

The cold and flu supplements market encompasses nutritional products designed to bolster immune function and alleviate symptoms associated with common colds and flu. These supplements often include vitamins, minerals, herbs, and amino acids, often formulated to support overall immune health and mitigate symptom severity. They are considered critical for preventing viral infections and recovering more swiftly, especially during peak seasons like fall and winter. The application of these supplements extends across different consumer demographics, including children, adults, and the elderly, with end-users ranging from health-conscious individuals to those seeking alternative solutions alongside conventional medicine.

KEY MARKET STATISTICS
Base Year [2023] USD 16.78 billion
Estimated Year [2024] USD 18.57 billion
Forecast Year [2030] USD 34.65 billion
CAGR (%) 10.90%

The market thrives due to increased health awareness, especially after recent global health crises emphasizing immune resilience. The trend towards preventive healthcare and natural supplements has driven significant growth, alongside online sales channels expanding market reach. Innovations in formulation and the growing trend for personalized nutrition are opening new avenues for product development, catering to a more individualized consumer experience. Despite these growth factors, the market faces significant challenges, including regulatory hurdles, the need for clinical validation of product efficacy, and competition from pharmaceuticals. Consumer skepticism regarding the effectiveness of some supplements further complicates market dynamics.

Potential opportunities lie in research and innovation, particularly in the development of scientifically backed supplements with proven health benefits. Companies can leverage digital platforms for innovative marketing strategies and consumer education initiatives that enhance product credibility. Additionally, expanding into emerging markets can provide access to a broader consumer base willing to invest in preventative healthcare solutions. However, companies need to maintain transparency in labeling and gather substantive scientific evidence to mitigate regulatory challenges and overcome consumer skepticism. This market demands continuous innovation, consumer engagement, and a focus on robust clinical research to sustain growth and establish trust among consumers seeking effective health interventions.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cold & Flu Supplements Market

The Cold & Flu Supplements Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Seasonal disease outbreaks and concerns about immune health of aging population
    • Rising consumer awareness through government health programs and initiatives
    • Emerging preferences for natural and herbal supplements
  • Market Restraints
    • Wider availability of pharmaceutical alternatives
  • Market Opportunities
    • Ongoing introduction of newly developed immunity booster supplements
    • Growing expansion of supermarkets and online distribution channels
  • Market Challenges
    • Challenges associated with maintaining product quality and adhering to regulatory requirements

Porter's Five Forces: A Strategic Tool for Navigating the Cold & Flu Supplements Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cold & Flu Supplements Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cold & Flu Supplements Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cold & Flu Supplements Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cold & Flu Supplements Market

A detailed market share analysis in the Cold & Flu Supplements Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cold & Flu Supplements Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cold & Flu Supplements Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cold & Flu Supplements Market

A strategic analysis of the Cold & Flu Supplements Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cold & Flu Supplements Market, highlighting leading vendors and their innovative profiles. These include Amway International Inc., Bayer AG, Church & Dwight Co., Inc., GlaxoSmithKline PLC, Haleon PLC, Himalaya Global Holdings Ltd., Johnson & Johnson Services Inc., Medique Products, Mondelez Global LLC, Nature's Sunshine Products, Inc., Nature's Way, Inc., Neurobiologix, Inc., Nutraceutical Corporation, Perrigo Company PLC, Reckitt Benckiser Group PLC, Sambucol by PharmaCare Laboratories Pty Ltd., Sun Pharmaceutical Industries Ltd., The Menarini Group, The Procter & Gamble Company, Thornton and Ross Limited by STADA Group, and Wakunaga Pharmaceutical Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Cold & Flu Supplements Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Herbal Extracts, Homeopathic, Natural Molecules, and Vitamins & Minerals.
  • Based on Form, market is studied across Pills & Capsules, Powders, and Syrups.
  • Based on Distribution Channel, market is studied across Online & E-commerce Platforms and Pharmacies & Drug Stores.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Seasonal disease outbreaks and concerns about immune health of aging population
      • 5.1.1.2. Rising consumer awareness through government health programs and initiatives
      • 5.1.1.3. Emerging preferences for natural and herbal supplements
    • 5.1.2. Restraints
      • 5.1.2.1. Wider availability of pharmaceutical alternatives
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing introduction of newly developed immunity booster supplements
      • 5.1.3.2. Growing expansion of supermarkets and online distribution channels
    • 5.1.4. Challenges
      • 5.1.4.1. Challenges associated with maintaining product quality and adhering to regulatory requirements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cold & Flu Supplements Market, by Type

  • 6.1. Introduction
  • 6.2. Herbal Extracts
  • 6.3. Homeopathic
  • 6.4. Natural Molecules
  • 6.5. Vitamins & Minerals

7. Cold & Flu Supplements Market, by Form

  • 7.1. Introduction
  • 7.2. Pills & Capsules
  • 7.3. Powders
  • 7.4. Syrups

8. Cold & Flu Supplements Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Online & E-commerce Platforms
  • 8.3. Pharmacies & Drug Stores

9. Americas Cold & Flu Supplements Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cold & Flu Supplements Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cold & Flu Supplements Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amway International Inc.
  • 2. Bayer AG
  • 3. Church & Dwight Co., Inc.
  • 4. GlaxoSmithKline PLC
  • 5. Haleon PLC
  • 6. Himalaya Global Holdings Ltd.
  • 7. Johnson & Johnson Services Inc.
  • 8. Medique Products
  • 9. Mondelez Global LLC
  • 10. Nature's Sunshine Products, Inc.
  • 11. Nature's Way, Inc.
  • 12. Neurobiologix, Inc.
  • 13. Nutraceutical Corporation
  • 14. Perrigo Company PLC
  • 15. Reckitt Benckiser Group PLC
  • 16. Sambucol by PharmaCare Laboratories Pty Ltd.
  • 17. Sun Pharmaceutical Industries Ltd.
  • 18. The Menarini Group
  • 19. The Procter & Gamble Company
  • 20. Thornton and Ross Limited by STADA Group
  • 21. Wakunaga Pharmaceutical Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. COLD & FLU SUPPLEMENTS MARKET RESEARCH PROCESS
  • FIGURE 2. COLD & FLU SUPPLEMENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. COLD & FLU SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. COLD & FLU SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. COLD & FLU SUPPLEMENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. COLD & FLU SUPPLEMENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY HERBAL EXTRACTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY HOMEOPATHIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY NATURAL MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY VITAMINS & MINERALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY PILLS & CAPSULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY POWDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY SYRUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY ONLINE & E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL COLD & FLU SUPPLEMENTS MARKET SIZE, BY PHARMACIES & DRUG STORES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM COLD & FLU SUPPLEMENTS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM COLD & FLU SUPPLEMENTS MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM COLD & FLU SUPPLEMENTS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. COLD & FLU SUPPLEMENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. COLD & FLU SUPPLEMENTS MARKET, FPNV POSITIONING MATRIX, 2023